跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Histaril - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Histaril
Approved
STANDARD
Histaril
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
def0df41aefcee74
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
def0df41aefcee74
Drug Approval Philippines Name
Histaril
Product Name
Histaril
Registration Number
DRP-7837
Brand Name
Histaril
Generic Name
Guaifenesin / Salbutamol (as Sulfate)
Dosage Form
Capsule
Dosage Strength
100 mg/2 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Aldril Pharmaceuticals, Inc.
Issuance Date
29 June 2024
Expiry Date
04 October 2029
Pharmacologic Category
Expectorant/ Selective Beta-2-Adrenoreceptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
def0df41aefcee74
Type
Standard
Back to Philippines FDA Approvals